Description
invited as CML expert by the International CML Foundation to present highlights of the past Conference of the European Haematology Association, EHA. Program: Clinical overview (Rüdiger Hehlmann) COVID-19 and CML (Rea, Breccia et al., S154) Personalized management and the new ELN Recommendations for treating CML (Hochhaus, Cortes et al, S153 / Saußele et al, S152) Monitoring MRD in CML: New developments (Cross) CML Genomics and the HARMONY PLUS project (Branford) Biological overview (Ilaria Pagani) Spotlight talk on Leukaemic stem cells (LSC's) on metabolism (Jones) Response, resistance and treatment-free remission in CML Mitochondrial DNA mutations are associated with response to imatinib in chronic myeloid leukemia patients (Pagani, S151) Loss of G0/G1 switch gene 2 (G0S2) in CML promotes TKI resistance by deregulating the mitochondrial electron transport chain (Gonzalez, S150) Q&A Session| Period | 2021 |
|---|---|
| Event title | iCMLf Conversation: CML Highlights of EHA |
| Event type | Other |
| Degree of Recognition | International |